Literature DB >> 24771266

Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity.

Fengqing Hu1, Zhen Tao, Zhenya Shen, Xiaolin Wang, Fei Hua.   

Abstract

Eph/ephrin signaling system plays a very important role in the tumorigenesis and the formation of blood vessel. However, the function of EphB4 and its ligand ephrin B2 in the carcinogenesis of esophageal squamous cell carcinoma (ESCC) is not fully understood. Here, it was found that the expression of EphB4 was up-regulated in ESCC tissues compared with the paired normal tissues, while ephrin B2 was down-regulated in ESCC samples. Phosphorylation of EphB4 induced by its ligand ephrin B2-Fc inhibited the growth, migration and colony formation of ESCC cells. Moreover, over-expression of EphB4 or EphB4 kinase dead mutant (EphB4 KD) in ESCC cells promoted cell growth and migration, suggesting EphB4 promoted cell growth and migration independent of its kinase activity. Furthermore, we found that EphB4 interacted with the adaptor protein RACK1 and RACK1 decreased the phosphorylation level of EphB4. Taken together, our study revealed the important function and regulation of EphB4 in the progression of ESCC and suggested EphB4 as a novel target for the treatment of ESCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24771266     DOI: 10.1007/s13277-014-1955-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  17 in total

Review 1.  Esophageal cancer.

Authors:  Peter C Enzinger; Robert J Mayer
Journal:  N Engl J Med       Date:  2003-12-04       Impact factor: 91.245

2.  Eph B4 receptor signaling mediates endothelial cell migration and proliferation via the phosphatidylinositol 3-kinase pathway.

Authors:  Jena J Steinle; Cynthia J Meininger; Reza Forough; Guoyao Wu; Mack H Wu; Harris J Granger
Journal:  J Biol Chem       Date:  2002-09-13       Impact factor: 5.157

3.  EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex.

Authors:  Guo Li; Xiao-Dan Ji; Hong Gao; Jiang-Sha Zhao; Jun-Feng Xu; Zhi-Jian Sun; Yue-Zhen Deng; Shuo Shi; Yu-Xiong Feng; Yin-Qiu Zhu; Tao Wang; Jing-Jing Li; Dong Xie
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

4.  RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.

Authors:  Yue-Zhen Deng; Fan Yao; Jing-Jing Li; Zheng-Fa Mao; Ping-Ting Hu; Ling-Yun Long; Guo Li; Xiao-Dan Ji; Shuo Shi; Dong-Xian Guan; Yuan-Yuan Feng; Lei Cui; Dang-Sheng Li; Yong Liu; Xiang Du; Ming-Zhou Guo; Li-Yan Xu; En-Min Li; Hong-Yang Wang; Dong Xie
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  EphB4 expression and biological significance in prostate cancer.

Authors:  Guangbin Xia; S Ram Kumar; Rizwan Masood; Sutao Zhu; Ramchandra Reddy; Valery Krasnoperov; David I Quinn; Susan M Henshall; Robert L Sutherland; Jacek K Pinski; Siamak Daneshmand; Maurizio Buscarini; John P Stein; Chen Zhong; Daniel Broek; Pradip Roy-Burman; Parkash S Gill
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

Review 7.  The role of ephrins and Eph receptors in cancer.

Authors:  Hanna Surawska; Patrick C Ma; Ravi Salgia
Journal:  Cytokine Growth Factor Rev       Date:  2004-12       Impact factor: 7.638

8.  Artery and vein size is balanced by Notch and ephrin B2/EphB4 during angiogenesis.

Authors:  Yung Hae Kim; Huiqing Hu; Salvador Guevara-Gallardo; Michael T Y Lam; Shun-Yin Fong; Rong A Wang
Journal:  Development       Date:  2008-11       Impact factor: 6.868

Review 9.  Extended esophagectomy with 3-field lymph node dissection for esophageal cancer.

Authors:  Mitsuo Tachibana; Shoichi Kinugasa; Hiroshi Yoshimura; Dipok Kumar Dhar; Naofumi Nagasue
Journal:  Arch Surg       Date:  2003-12

10.  RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma.

Authors:  Fengqing Hu; Zhen Tao; Mingsong Wang; Guoqing Li; Yunjiao Zhang; Hong Zhong; Haibo Xiao; Xiao Xie; Mei Ju
Journal:  Tumour Biol       Date:  2013-07-27
View more
  5 in total

Review 1.  EphB4: A promising target for upper aerodigestive malignancies.

Authors:  Ravi Salgia; Prakash Kulkarni; Prakash S Gill
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-01-31       Impact factor: 10.680

Review 2.  Paradoxes of the EphB1 receptor in malignant brain tumors.

Authors:  Wenqiang Wei; Hongju Wang; Shaoping Ji
Journal:  Cancer Cell Int       Date:  2017-02-08       Impact factor: 5.722

3.  Targeting Forward and Reverse EphB4/EFNB2 Signaling by a Peptide with Dual Functions.

Authors:  Chiyi Xiong; Yunfei Wen; Jun Zhao; Dengke Yin; Lingyun Xu; Anca Chelariu-Raicu; Cody Yao; Xiaohong Leng; Jinsong Liu; Rajan R Chaudhari; Shuxing Zhang; Anil K Sood; Chun Li
Journal:  Sci Rep       Date:  2020-01-16       Impact factor: 4.379

Review 4.  Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.

Authors:  Luying He; Zhangfeng Zhong; Man Chen; Qilian Liang; Yitao Wang; Wen Tan
Journal:  Front Pharmacol       Date:  2022-01-03       Impact factor: 5.988

5.  Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.

Authors:  Tae Ho Lee; Jin Hyung Heo; Ju Yeon Jeong; Gee Hoon Lee; Dong Soo Park; Tae Hoen Kim
Journal:  Yonsei Med J       Date:  2021-08       Impact factor: 2.759

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.